-
Sector Analysis
Lyme Disease (LD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in LD Therapeutics. In 2024 and 2029, Germany is anticipated to have the highest number of incident cases of Lyme disease, representing a large portion of global cases. Currently, the Lyme disease market is saturated with generic drugs, and the penicillin-binding protein (PBP) inhibitor drug class dominates the approved innovator drugs currently available to treat Lyme disease. The Lyme disease pipeline holds 23 molecules, with no asset...
-
Product Insights
Dengue Fever Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Dengue Fever - Global Clinical Trials Review, 2025" provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Vulvovaginal Candidiasis (VVC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in VVC Therapeutics. In 2024 and 2029, China is anticipated to have the highest number of lifetime diagnosed prevalent cases of VVC, representing a large portion of global cases. In 2024. Currently, the VVC market is saturated with generic drugs, and the lanosterol 14 alpha demethylase inhibitor drug class dominates the approved innovator drugs to treat VVC. The VVC pipeline holds nine molecules, with one asset in...
-
Sector Analysis
Clostridioides difficile Infections (CDI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in CDI Therapeutics. In 2024, there were more than 2.04 million diagnosed incident cases of CDI in the 16 countries covered in GlobalData’s epidemiology forecast. The current CDI market is dominated by several companies marketing genericized antibiotic therapies. The CDI pipeline holds 48 molecules, with five molecule present in Phase III development. Over the past 10 years, commercial sponsors headed trials for CDI, led by Pfizer (seven...
-
Sector Analysis
Chronic Hepatitis B (CHB) Epidemiology Analysis and Forecast to 2034
Chronic hepatitis B (CHB) is a liver disease caused by the hepatitis B virus (HBV). HBV is transmitted via blood, semen, and other body fluids, and is commonly spread through sexual contact, needle sharing, accidental needlesticks, and vertically from a pregnant person to the newborn (Mayo Clinic, 2024). HBV infection can be prevented with a vaccine. For most people, HBV infection is a short-term, acute illness resulting in a full recovery in less than six months. For others, infection lasts...
-
Product Insights
Pulmonary Tuberculosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Pulmonary Tuberculosis- Global Clinical Trials Review, 2025" provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025" provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2025" provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Tuberculosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Tuberculosis - Global Clinical Trials Review, 2025" provides an overview of Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Meningitis - Global Clinical Trials Review, 2025" provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.